Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Article
Time will define Juvederm's place among HA fillers
National report - Many in dermatology are anxiously anticipating the arrival of the latest addition to the hyaluronic acid filler market, Juvederm (Allergan Medical), as a new alternative to the long-held gold standard, Restylane (Medicis ?sthetics).
Related Videos
Related Content
